TASKA CX accessories

TASKA Announces Next Chapter in the United States

2026-10-23


Today, we are pleased to share an important milestone in TASKA's journey. TASKA will transition from its current U.S. distributorship arrangement and move to a direct operating model in the United States. The current agreement with Fillauer will conclude on 31 March 2027.

This change reflects TASKA's long-term commitment to supporting clinicians, users, researchers, and industry partners more closely. By establishing a direct presence in the United States, we will be better positioned to invest in customer support, clinical engagement, training, and future innovation.

Most importantly, nothing changes for customers today.

Current ordering processes, support channels, warranty arrangements, repairs, and product availability all remain unchanged. Clinicians and users should continue working with their existing contacts and support teams as normal.

As part of this transition, TASKA is establishing a dedicated facility in Salt Lake City, Utah. The facility will support sales, customer support, repairs and servicing, clinical engagement, training, education, and future innovation activities.

We recognise that continuity of care is critical. Throughout the transition period, TASKA, Fillauer, Motion Control, and Hanger will work together to ensure a smooth and professional transition that prioritises clinicians and users.

We will continue to share updates as plans progress and look forward to the opportunities this next chapter creates for the upper limb community.

Click here for the official press release

-

Frequently Asked Questions

What has TASKA announced?

TASKA has announced that it will transition from its current U.S. distributorship arrangement with Fillauer and move to a direct operating model in the United States. The current agreement will conclude on 31 March 2027.

Why is TASKA making this change?

As TASKA continues to grow, we believe having a direct presence in the United States will allow us to work more closely with clinicians, users, researchers, and industry partners. This is part of our long-term commitment to advancing upper limb prosthetic care and innovation. Fillauer, Motion Control, and more recently Hanger have played an important role in helping establish and grow TASKA in the United States. We remain grateful for their partnership and support over many years and look forward to continuing working with them.

When will the transition take place?

The current arrangement remains in place until 31 March 2027. Until then, all existing processes and support channels remain unchanged.

What does this mean for me today?

Nothing changes today. It is business as usual. Continue to:

  • Order products through existing channels.
  • Request support through existing channels.
  • Send repairs and service requests through existing channels.
  • Work with your usual contacts.

Will product availability change?

No. We expect product availability and support to continue as normal throughout the transition period.

Where should I send hands for service or repair?

Until further notice, please continue sending all service and repair work through Fillauer Motion Control in Salt Lake City. Any future changes will be communicated well in advance.

Will there be any changes to warranty support?

No. Existing warranty processes and support arrangements remain unchanged.

Who should I contact for technical support?

Please continue using your current support channels and contacts. Any future changes will be communicated before they take effect.

Is TASKA opening a U.S. facility?

Yes. TASKA is establishing a dedicated facility in Salt Lake City, Utah.

What will the new facility support?

From 1 April 2027, the new facility will support:

  • Sales.
  • Customer support.
  • Repairs and servicing.
  • Clinical engagement.
  • Training and education.
  • Future innovation activities.

Will there be any interruption to patient care?

Our goal is to ensure no disruption to patient care. Continuity and support for clinicians and users are central priorities throughout the transition period.

What does this mean for existing TASKA users?

Existing users can continue to use their devices with confidence. Service, support, repairs, and warranty processes remain unchanged throughout the transition period.

How will TASKA keep clinicians informed?

We will provide regular updates through:

  • Email communications.
  • Our website.
  • Clinical education events.

Who can I contact if I have additional questions?

Please contact your usual TASKA or Fillauer representative, or you can email support@taskaprosthetics.com

Woman using a TASKA CX prosthetic hand to tap the Grip List in the MyTASKA app on her phone.

Stay in touch.

Join our mailing list to be the first to find out about product updates, handy tips and more.

Subscribe

You can unsubscribe from our newsletter at any time. We do not sell or distribute your email address to any third party. Please view our privacy policy.